US Patent 11834435 SSTR4 agonist salts
Patent 11834435 was granted and assigned to Eli Lilly and Company on December, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+25 properties)
Article (+353 characters)
US Patent 11834435 SSTR4 agonist salts
Article
Patent abstract
The present invention relates to specific salts of (1S,5R)-(1α,5α,6α)-N-[1,1-dimethyl-2-[(3-methyl-2-pyridyl)oxy]ethyl]-3-azabicyclo[3.1.0]hexane-6-carboxamide, to pharmaceutical compositions comprising said salts, to methods of using said salts to treat physiological disorders, and to intermediates useful in the synthesis of the salts.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
David Andrew Coates0
David Michael Remick0
Date of Patent
December 5, 2023
0Patent Application Number
179444290
Date Filed
September 14, 2022
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11834435 SSTR4 agonist salts
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
